Treatment of colorectal liver metastases

Background: Surgical resection is the only potentially curative treatment f or colorectal liver metastases, with 5-year survival rates approaching 40 p er cent. However, at present only 20-25 per cent of such lesions are deemed resectable. This review examines developments in neoadjuvant and adjuvant treatments of colorectal liver metastases that aim to improve the results o f surgical management of this disease. Methods: A literature review was undertaken based on a Medline search from 1970 to May 1998. Results: Further evolution in surgical technique is unlikely to lead to a d ramatic increase in the resectability rate of colorectal liver metastases. Recent developments in neoadjuvant and adjuvant chemotherapy schedules, tog ether with a range of interventional radiological procedures and interstiti al lyric techniques, show promise in terms of extending the limits of resec tability and decreasing recurrence rates associated with these lesions. Usi ng multimodality regimens 5-year survival rates of 40 per cent are now bein g reported for lesions that were initially considered irresectable. Conclusion: Patients with colorectal liver metastases should be assessed in units that can offer all the specialist techniques necessary to deliver op timum care. Incorporation of newer neoadjuvant and adjuvant treatments into management strategies should occur in the setting of randomized trials.